Literature DB >> 23613032

Temporally consistent probabilistic detection of new multiple sclerosis lesions in brain MRI.

Colm Elliott1, Douglas L Arnold, D Louis Collins, Tal Arbel.   

Abstract

Detection of new Multiple Sclerosis (MS) lesions on magnetic resonance imaging (MRI) is important as a marker of disease activity and as a potential surrogate for relapses. We propose an approach where sequential scans are jointly segmented, to provide a temporally consistent tissue segmentation while remaining sensitive to newly appearing lesions. The method uses a two-stage classification process: 1) a Bayesian classifier provides a probabilistic brain tissue classification at each voxel of reference and follow-up scans, and 2) a random-forest based lesion-level classification provides a final identification of new lesions. Generative models are learned based on 364 scans from 95 subjects from a multi-center clinical trial. The method is evaluated on sequential brain MRI of 160 subjects from a separate multi-center clinical trial, and is compared to 1) semi-automatically generated ground truth segmentations and 2) fully manual identification of new lesions generated independently by nine expert raters on a subset of 60 subjects. For new lesions greater than 0.15 cc in size, the classifier has near perfect performance (99% sensitivity, 2% false detection rate), as compared to ground truth. The proposed method was also shown to exceed the performance of any one of the nine expert manual identifications.

Entities:  

Mesh:

Year:  2013        PMID: 23613032     DOI: 10.1109/TMI.2013.2258403

Source DB:  PubMed          Journal:  IEEE Trans Med Imaging        ISSN: 0278-0062            Impact factor:   10.048


  17 in total

1.  Longitudinal multiple sclerosis lesion segmentation: Resource and challenge.

Authors:  Aaron Carass; Snehashis Roy; Amod Jog; Jennifer L Cuzzocreo; Elizabeth Magrath; Adrian Gherman; Julia Button; James Nguyen; Ferran Prados; Carole H Sudre; Manuel Jorge Cardoso; Niamh Cawley; Olga Ciccarelli; Claudia A M Wheeler-Kingshott; Sébastien Ourselin; Laurence Catanese; Hrishikesh Deshpande; Pierre Maurel; Olivier Commowick; Christian Barillot; Xavier Tomas-Fernandez; Simon K Warfield; Suthirth Vaidya; Abhijith Chunduru; Ramanathan Muthuganapathy; Ganapathy Krishnamurthi; Andrew Jesson; Tal Arbel; Oskar Maier; Heinz Handels; Leonardo O Iheme; Devrim Unay; Saurabh Jain; Diana M Sima; Dirk Smeets; Mohsen Ghafoorian; Bram Platel; Ariel Birenbaum; Hayit Greenspan; Pierre-Louis Bazin; Peter A Calabresi; Ciprian M Crainiceanu; Lotta M Ellingsen; Daniel S Reich; Jerry L Prince; Dzung L Pham
Journal:  Neuroimage       Date:  2017-01-11       Impact factor: 6.556

2.  Intensity based methods for brain MRI longitudinal registration. A study on multiple sclerosis patients.

Authors:  Yago Diez; Arnau Oliver; Mariano Cabezas; Sergi Valverde; Robert Martí; Joan Carles Vilanova; Lluís Ramió-Torrentà; Alex Rovira; Xavier Lladó
Journal:  Neuroinformatics       Date:  2014-07

3.  A subtraction pipeline for automatic detection of new appearing multiple sclerosis lesions in longitudinal studies.

Authors:  Onur Ganiler; Arnau Oliver; Yago Diez; Jordi Freixenet; Joan C Vilanova; Brigitte Beltran; Lluís Ramió-Torrentà; Alex Rovira; Xavier Lladó
Journal:  Neuroradiology       Date:  2014-03-04       Impact factor: 2.804

4.  Improved Automatic Detection of New T2 Lesions in Multiple Sclerosis Using Deformation Fields.

Authors:  M Cabezas; J F Corral; A Oliver; Y Díez; M Tintoré; C Auger; X Montalban; X Lladó; D Pareto; À Rovira
Journal:  AJNR Am J Neuroradiol       Date:  2016-06-09       Impact factor: 3.825

5.  A hybrid approach based on logistic classification and iterative contrast enhancement algorithm for hyperintense multiple sclerosis lesion segmentation.

Authors:  Antonio Carlos da Silva Senra Filho
Journal:  Med Biol Eng Comput       Date:  2017-11-18       Impact factor: 2.602

Review 6.  Recent advances in the longitudinal segmentation of multiple sclerosis lesions on magnetic resonance imaging: a review.

Authors:  Marcos Diaz-Hurtado; Eloy Martínez-Heras; Elisabeth Solana; Jordi Casas-Roma; Sara Llufriu; Baris Kanber; Ferran Prados
Journal:  Neuroradiology       Date:  2022-07-22       Impact factor: 2.995

7.  Safety and efficacy of tolebrutinib, an oral brain-penetrant BTK inhibitor, in relapsing multiple sclerosis: a phase 2b, randomised, double-blind, placebo-controlled trial.

Authors:  Daniel S Reich; Douglas L Arnold; Patrick Vermersch; Amit Bar-Or; Robert J Fox; Andre Matta; Timothy Turner; Erik Wallström; Xinyan Zhang; Miroslav Mareš; Farit A Khabirov; Anthony Traboulsee
Journal:  Lancet Neurol       Date:  2021-09       Impact factor: 59.935

8.  Validation of White-Matter Lesion Change Detection Methods on a Novel Publicly Available MRI Image Database.

Authors:  Žiga Lesjak; Franjo Pernuš; Boštjan Likar; Žiga Špiclin
Journal:  Neuroinformatics       Date:  2016-10

9.  Dice Overlap Measures for Objects of Unknown Number: Application to Lesion Segmentation.

Authors:  Ipek Oguz; Aaron Carass; Dzung L Pham; Snehashis Roy; Nagesh Subbana; Peter A Calabresi; Paul A Yushkevich; Russell T Shinohara; Jerry L Prince
Journal:  Brainlesion       Date:  2018-02-17

10.  Effects of Ibudilast on MRI Measures in the Phase 2 SPRINT-MS Study.

Authors:  Robert T Naismith; Robert A Bermel; Christopher S Coffey; Andrew D Goodman; Janel Fedler; Marianne Kearney; Eric C Klawiter; Kunio Nakamura; Sridar Narayanan; Christopher Goebel; Jon Yankey; Elizabeth Klingner; Robert J Fox
Journal:  Neurology       Date:  2020-12-02       Impact factor: 9.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.